Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2017-2023
Historical Year
2024-2032
Forecast Year
Global Retinitis Pigmentosa Treatment Market Outlook
The global retinitis pigmentosa treatment market is being driven by the growth of the retinal disorder treatment market. The global retinal disorder treatment market is expected to grow at a CAGR of 6.8% in the forecast period of 2024-2032 to reach a value of USD 24.41 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The Asia Pacific Region to Witness the Fastest Growth in the Retinitis Pigmentosa Treatment Industry, Owing to a Large Patient Pool
The market for retinitis pigmentosa is supported by the large share of the market from the North America and Europe region collectively. This can be attributed to the upcoming approvals, and a surge in the number of research and awareness regarding the disorder, greater affordability, rise in product offerings, and an increase in demand for early treatment. The trend is expected to persist in the forecast period as well. The Asia Pacific region is expected to accelerate at a high rate over the forecast period. The region is governed by factors, such as the rise in the adoption of new products, large patient pool, and an increase in the demand for retinitis pigmentosa treatment in the emerging economies, like India and China. The market is also positively influenced by the inflating disposable incomes, changing lifestyles, and rapid urbanisation.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Retinitis Pigmentosa Treatment: Market Segmentation
Retinitis pigmentosa treatment refers to the treatment of retinitis pigmentosa, which is a group of rare genetic disorders, which entail the breakdown and loss of cells in the retina. Common symptoms of retinitis pigmentosa include problems in seeing at night and a loss of peripheral vision.
On the basis of type, the market is divided into:
- Autosomal Recessive RP
- Autosomal Dominant RP
- X-Linked RP
Based on treatment, the industry can be segmented into:
- Drug
- Device
- Surgery
Drug is divided on the basis of type into vitamin A palmitate and acetazolamide, among others. Device is further divided on the basis of type into sunglasses, implants, and others. Surgery is divided on the basis of type into retinal transplantation and corneal neurotization, among others.
On the basis of distribution channel, the industry is categorised into:
- Hospital Retailer
- Retail Retailer
- Online
Based on end use, the industry is segmented into:
- Hospitals
- Special Clinics
- Home Care
- Ophthalmologist
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rise in the Patients Suffering from Retinitis Pigmentosa to Aid the Retinitis Pigmentosa Treatment Industry Growth
The market for retinitis pigmentosa treatment is being driven by the rise in the patients suffering from retinitis pigmentosa across the globe. The market forces, such as rich product pipeline and increase in the funds for researchers developing new innovative drugs for the treatment of retinitis pigmentosa, are expected to aid the market growth of retinitis pigmentosa treatment over the forecast period. In addition, the rise in the special designation from the supervisory to offer a treatment to the patients as soon as possible is invigorating the market growth.
Key Industry Players in the Global Retinitis Pigmentosa Treatment Market
The report gives a detailed analysis of the following key players in the global retinitis pigmentosa treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Ionis Pharmaceuticals, Inc.
- Orphagen Pharmaceuticals, Inc.
- ReNeuron Group plc
- Ocugen, Inc.
- MeiraGTx Limited.
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Treatment |
|
| Breakup by Distribution Channel |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The global retinitis pigmentosa treatment market is being driven by the rising retinal disorder treatment market, which is projected to grow at a CAGR of 6.8% between 2024 and 2032.
The global retinal disorder treatment market is estimated to reach about USD 24.41 billion by 2032 and is expected to continue to support the growth of the retinitis pigmentosa treatment industry.
The major drivers of the industry, such as the surge in the number of research and awareness regarding the disorder, greater affordability, rise in product offerings, and an increase in demand for early treatment, are expected to aid the market growth.
The key trend guiding the growth of the market includes the increase in the funds for researchers developing new innovative drugs for the treatment of retinitis pigmentosa.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The significant types of retinitis pigmentosa treatment in the market are autosomal recessive RP, autosomal dominant RP, and X-linked RP.
The treatments of retinitis pigmentosa include drug, device, and surgery.
The major distribution channel in the industry are hospital retailer, retail retailer, and online.
The leading end use sectors in the market are hospitals, special clinics, home care, and ophthalmologist, among others.
The major players in the industry are Ionis Pharmaceuticals, Inc., Orphagen Pharmaceuticals, Inc., ReNeuron Group plc, Ocugen, Inc., and MeiraGTx Limited., among others.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124